Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michela Brena is active.

Publication


Featured researches published by Michela Brena.


JAMA Dermatology | 2015

The Phenotypic and Genotypic Spectra of Ichthyosis With Confetti Plus Novel Genetic Variation in the 3' End of KRT10 From Disease to a Syndrome

Iris Spoerri; Michela Brena; Julie De Mesmaeker; Schlipf N; Judith Fischer; Gianluca Tadini; Peter Itin; Bettina Burger

IMPORTANCE Ichthyosis with confetti (IWC) is a genodermatosis caused by dominant negative mutations in the gene encoding keratin 10 (KRT10). We investigated clinical and genetic details of a substantial number of patients with IWC in order to define major and minor criteria for diagnosis of this rare disorder. OBSERVATIONS Parallel clinical investigation of 6 patients with IWC revealed a novel spectrum of phenotypes. We found several features that qualify as major criteria for diagnosis, which are clearly and consistently associated with the condition. These included malformation of ears, hypoplasia of mammillae, and dorsal acral hypertrichosis. Genetic analysis of patients revealed several different frameshift mutations in intron 6 or exon 7 of KRT10. Analysis of this locus in 17 unrelated control individuals revealed 2 novel polymorphisms of KRT10. CONCLUSIONS AND RELEVANCE We present for the first time to our knowledge the spectrum of clinical variability of IWC in 6 patients with confirmed mutations in KRT10. From this, we have extracted major and minor criteria to aid early and correct clinical diagnosis. Ectodermal malformations, present in all patients, suggest a novel classification of IWC as a syndrome. There is remarkable genetic variation at the IWC disease locus within control individuals from the general population.


Pediatric Dermatology | 2014

Familial papular epidermal nevus with "skyline" basal cell layer

Michela Brena; Francesca Besagni; Vinicio Boneschi; Gianluca Tadini

Papular epidermal nevus with “skyline” basal cell layer (PENS), a novel keratinocytic nevus, has recently been described as a mosaic condition with varying presentations. We herein describe typical PENS lesions, which usually occur sporadically, affecting two members of the same family. The concept of paradominant inheritance is proposed to explain the paradox of occasional transmission of normally sporadically occurring traits.


American Journal of Medical Genetics Part A | 2013

X‐linked reticulate pigmentary disorder with systemic manifestations: A new family and review of the literature

Lidia Pezzani; Michela Brena; Michele Callea; Marina Colombi; Gianluca Tadini

X‐linked reticulate pigmentation disorder with systemic manifestations (XLPDR) is an extremely rare genodermatosis with recessive X‐linked inheritance but unknown molecular basis. In males, cutaneous involvement is characterized by reticulate hyperpigmentation of the skin that is associated with a typical facies and severe systemic involvement. In the carrier females, manifestations are apparently limited to the skin with patchy linear hyperpigmentation following the lines of Blaschko that are similar to stage III incontinentia pigmenti. Thus far, only five families affected by this disorder have been described. We report on a new family with clinical features of XLPDR and compare it with those reported in the literature.


Pediatric Dermatology | 2013

Papular Epidermal Nevus with “Skyline” Basal Cell Layer (PENS) Following a Blaschko Linear Pattern

Elisa Faure; Gianluca Tadini; Michela Brena; Lucia Restano Cassulini

Papular epidermal nevus with “skyline” basal cell layer (PENS), a variant of epidermal nevi, has recently been described as a small, round or polygonal papule, visible at birth or shortly thereafter, with characteristic histopathologic features. It has been considered a separate entity from keratinocytic nevi because no lesion observed thus far has followed any of the known archetypical mosaic patterns. Here we describe for the first time a PENS lesion following a linear distribution pattern along Blaschkos lines.


Journal of Cutaneous Pathology | 2013

Nevoid follicular mucinosis: a new type of hair follicle nevus

Gianluca Tadini; Maria Pia Boldrini; Michela Brena; Lidia Pezzani; Lorenzo Marchesi; Franco Rongioletti

Follicular mucinosis represents a term for a histopathologic reaction pattern in follicular epithelium. It is a characteristic of alopecia mucinosa. However, it may also occur in a variety of unrelated conditions. Epidermal nevi are considered to be hamartomatous disorders and they can show a predominant component of non‐organoid (keratinocytes) and/or organoid nevi. All the cases of epidermal nevi described with mucin deposits until now are reported as mucinous nevus or mucinous eccrine nevus; in the first type of disorder, diffuse mucin deposition is only seen in the papillary dermis, and in the second type, the mucin is found around the proliferation of eccrine structures. We believe this is the first reported case of epidermal nevus along Blaschkos lines exhibiting typical microscopic findings of mucinosis exclusively distributed inside the follicular epithelia.


International Journal of Dermatology | 2018

Treatment of common recalcitrant warts with topical formic acid

Rossana Schianchi; Michela Brena; Stefano Veraldi

Treatment of common recalcitrant warts with topical formic acid Dear Editor, In 2001, Bhat et al. published in this journal the results of an open, placebo-controlled, nonrandomized trial on the treatment of common warts with topical 85% formic acid. In the summer of 2016, a “pen” (Endwarts pen ) containing formic acid was marketed in Italy. We present the results of an open, sponsor-free study on the efficacy and tolerability of this pen in patients with common recalcitrant warts. Diagnosis of warts was clinical. The case list is made up of 23 Caucasian, immunocompetent patients (17 males and 6 females, aged 18–33 years [mean age: 23.2 years]), with a total of 93 warts located on the face, elbows, hands, and knees. One patient was pregnant. All patients were previously, although unsuccessfully, treated at other centers with at least two different therapeutic modalities: curettage (18 patients), salicylic acid (16 patients), cryotherapy (13 patients), electrodesiccation (11 patients), laser therapy (8 patients), imiquimod (5 patients), and surgical excision (1 patient). Although the guidelines of the manufacturer suggest an application time of 1 second, the pen was applied on each wart for 30 seconds, twice weekly for 6 weeks. The choice of this duration was owing to the fact that in a previous group of eight patients, treated with an application time of 1 second, only mild improvement of the lesions was observed. No other topical or systemic drugs were used. No physical or surgical treatments were used. Eighteen of 23 patients were considered as evaluable: five patients were lost to follow-up (these patients were affected by a total of 9 warts: 93 9 = 84 warts). At the end of the treatment, a total number of 36 warts disappeared (36 out of 84 = 42.8%). Complete remission was observed in eight patients who had a range of 1–4 warts before the beginning of the treatment. No differences with regard to therapeutic response between warts in different locations were observed. One patient reported a mild burning sensation on the area of application, but it was unnecessary to stop the treatment. No cases of pain were reported. Formic acid is a carboxylic acid. It appears as a colorless liquid with a typical smell. In nature, it is found in red ants (Formica rufa) and stinging nettles (Urtica dioica). To our knowledge, three clinical studies on the treatment of common warts with formic acid have been published. In the first one, 50 patients were treated with 85% formic acid and 50 patients received placebo (water), using a needle puncture technique every other day. Ninety-two percent of patients who were treated with formic acid showed complete disappearance of warts after 3–4 weeks of treatment, compared to 6% in the placebo group. A case control, double-blind trial was performed in 79 students, aged 12–17 years, with common warts located on the scalp, hands, trunk, and feet. One group of 42 patients was treated with 85% formic acid; the control group consisted of 37 patients who were treated with water as placebo. Applications were done on alternate days for 4 weeks. The total number of applications was limited to 12, after which the treatment was considered a failure. In case and control groups, the average number of applications required for the warts to disappear was 5.9 3.8 vs. 11.1 2.6, respectively. The efficacy of the treatment, assessed at the end of the first month as complete or partial remissions, was 81% vs. 9.5% and 11% vs. 2.7%, respectively. An additional placebo-controlled trial was performed in 2010. A total of 34 patients received 85% formic acid on their lesion on one side of the body and distilled water as placebo on the other side of the body, every other day, using a needle puncture technique. Follow-up was every 2 weeks up to 3 months. Ninety-one percent of patients who were treated with formic acid showed complete disappearance of warts after the follow-up period, compared to 10% in the placebo group. Mechanisms of action of formic acid in warts remain unknown. According to some authors, it acts like formalin by dehydrating and finally destroying the infected tissue. This would be demonstrated by the fact that the warts become slightly white in color, followed by desquamation of the superficial layers. In all studies, it was stated that the treatment with formic acid is inexpensive, easy, fast, safe (it can also be used in pregnancy, as in our patient), and painless. Adherence to treatment and compliance are therefore very high. However, one case of a deep full thickness burn from formic acid application was reported. This patient developed a burn over the proximal interphalangeal joint of her fifth finger, after inappropriate application of formic acid. The burn required debridement and reconstruction using a subcutaneous flap from the adjacent finger (a reverse cross finger flap). The results of our study may be summarized as follows: (i) formic acid was able to cure more than 42% of common warts that were previously resistant to a number of pharmacologic and surgical treatments. This percentage can be considered, in our personal clinical experience, as good: the very high percentage of complete remissions reported by two of the previously cited trials (92% and 91%, respectively) is very surprising; (ii) no important side effects were reported or observed, and as previously mentioned, only one patient reported mild irritation. A controlled clinical study is necessary to confirm or disprove our results.


Case Reports in Dermatology | 2016

A Second Case of Gobello Nevus Syndrome

Gianluca Tadini; Luisa Carlotta Rossi; Elisa Faure; Francesca Besagni; Vinicio Boneschi; Susanna Esposito; Michela Brena

An uncommon type of epidermal nevus characterized by hyperpigmented hyperkeratotic bands following a Blaschko-linear pattern and generalized follicular hyperkeratosis were observed in a 17-year-old male patient who additionally showed tufted hair folliculitis on the scalp and clinodactyly of the fifth finger of both hands. The combination of epidermal nevus with skeletal abnormalities was first described by Gobello et al. [Dermatology 2000;201:51-55] as a new epidermal nevus syndrome that was named after the first author of this work. Our case shows identical clinical and histopathological features and represents the second case of this rare syndrome reported in the literature.


Archive | 2014

Diagnostica molecolare delle genodermatosi

Gianluca Tadini; Lidia Pezzani; Michela Brena; Maria Pia Boldrini

E passato poco piu di un ventennio dai primi approcci non clinici per la diagnosi delle malattie genetiche cutanee: in questo spazio di tempo la comunita scientifica internazionale ha coperto una distanza cosmica.


Dermatology | 2013

Anemic nevus in neurofibromatosis type 1.

Gianluca Tadini; Michela Brena; Lidia Pezzani; Carlo Gelmetti; Santagada F; M.P. Boldrini


Archive | 2005

Atlas of Genodermatoses

Gianluca Tadini; Michela Brena; Carlo Gelmetti; Lidia Pezzani

Collaboration


Dive into the Michela Brena's collaboration.

Top Co-Authors

Avatar

Gianluca Tadini

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlo Gelmetti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vinicio Boneschi

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Athanasia Tourlaki

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge